IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$1.12
52W Range
$0.48 - $1.66
50D Avg
$1.29
200D Avg
$0.92
Market Cap
$64.49M
Avg Vol (3M)
$319.60K
Beta
2.31
Div Yield
-
ICCM Company Profile
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
ICCM Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Annual
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| INDIA | $413.00K | - | - |
| ISRAEL | $30.00K | $30.00K | $30.00K |
| CHINA | $41.00K | $440.00K | - |
| JAPAN | $481.00K | $480.00K | $1.13M |
| Other Countries Member | $1.46M | $1.51M | $1.29M |
| UNITED STATES | $870.00K | $751.00K | $604.00K |
| THAILAND | - | $14.00K | $30.00K |
Latest
Fiscal year ends in Dec 23 | Currency in USD
Peer Comparison
| Ticker | Company |
|---|---|
| SINT | Sintx Technologies, Inc. |
| TMCI | Treace Medical Concepts, Inc. |
| ESTA | Establishment Labs Holdings Inc. |
| KIDS | OrthoPediatrics Corp. |
| CNMD | CONMED Corporation |
| BWAY | BrainsWay Ltd. |
| CLPT | ClearPoint Neuro, Inc. |
| SGHT | Sight Sciences, Inc. |
| NPCE | NeuroPace, Inc. |
| SSKN | STRATA Skin Sciences, Inc. |
| TELA | TELA Bio, Inc. |
| TNON | Tenon Medical, Inc. |
| CTSO | Cytosorbents Corporation |
| SRDX | Surmodics, Inc. |
| ITGR | Integer Holdings Corporation |